125 related articles for article (PubMed ID: 30428081)
1. Arsenic May Act as a Pro-Metastatic Carcinogen Through Promoting Tumor Cell-Induced Platelet Aggregation.
Kim K; Heo YK; Chun S; Kim CH; Bian Y; Bae ON; Lee MY; Lim KM; Chung JH
Toxicol Sci; 2019 Mar; 168(1):18-27. PubMed ID: 30428081
[TBL] [Abstract][Full Text] [Related]
2. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils.
Taylor ML; Ilton MK; Misso NL; Watkins DN; Hung J; Thompson PJ
Br J Clin Pharmacol; 1998 Aug; 46(2):139-45. PubMed ID: 9723822
[TBL] [Abstract][Full Text] [Related]
3. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA.
Dardik R; Savion N; Kaufmann Y; Varon D
Br J Cancer; 1998 Jun; 77(12):2069-75. PubMed ID: 9649116
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454.
Amirkhosravi A; Mousa SA; Amaya M; Blaydes S; Desai H; Meyer T; Francis JL
Thromb Haemost; 2003 Sep; 90(3):549-54. PubMed ID: 12958625
[TBL] [Abstract][Full Text] [Related]
5. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb/IIIa-dependent process.
Pang JH; Coupland LA; Freeman C; Chong BH; Parish CR
Clin Exp Metastasis; 2015 Jun; 32(5):495-505. PubMed ID: 25982688
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.
Nannizzi-Alaimo L; Alves VL; Phillips DR
Circulation; 2003 Mar; 107(8):1123-8. PubMed ID: 12615789
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
Qian W; Tao L; Wang Y; Zhang F; Li M; Huang S; Wang A; Chen W; Yue Z; Chen L; Liu Y; Huang C; Zhang L; Li Y; Lu Y
J Vasc Res; 2015; 52(3):197-209. PubMed ID: 26488158
[TBL] [Abstract][Full Text] [Related]
8. Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin.
Mousa SA; Forsythe M; Bozarth J; Jin F; Confalone PN
Coron Artery Dis; 2000 Oct; 11(7):563-70. PubMed ID: 11023245
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
10. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2.
Lucotti S; Cerutti C; Soyer M; Gil-Bernabé AM; Gomes AL; Allen PD; Smart S; Markelc B; Watson K; Armstrong PC; Mitchell JA; Warner TD; Ridley AJ; Muschel RJ
J Clin Invest; 2019 Mar; 129(5):1845-1862. PubMed ID: 30907747
[TBL] [Abstract][Full Text] [Related]
11. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
12. Effect of aspirin on platelet desaggregation induced by SR121566, a potent GP-IIb/IIIa antagonist.
Savi P; Bernat A; Lalé A; Roque C; Zamboni G; Herbert JM
Platelets; 2000 Feb; 11(1):43-8. PubMed ID: 10938881
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
[TBL] [Abstract][Full Text] [Related]
14. Polyamines inhibit both platelet aggregation and glycoprotein IIb/IIIa activation.
Corona-de-la-Peña N; Uribe-Carvajal S; Barrientos-Rios R; Matias-Aguilar L; Montiel-Manzano G; Majluf-Cruz A
J Cardiovasc Pharmacol; 2005 Aug; 46(2):216-21. PubMed ID: 16044034
[TBL] [Abstract][Full Text] [Related]
15. Arsenic induces platelet shape change through altering focal adhesion kinase-mediated actin dynamics, contributing to increased platelet reactivity.
Kim K; Shin EK; Chung JH; Lim KM
Toxicol Appl Pharmacol; 2020 Mar; 391():114912. PubMed ID: 32014540
[TBL] [Abstract][Full Text] [Related]
16. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
17. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro.
Scholz T; Zhao L; Temmler U; Bath P; Heptinstall S; Lösche W
Platelets; 2002 Nov; 13(7):401-6. PubMed ID: 12487787
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions.
Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K
J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
Judge HM; Buckland RJ; Holgate CE; Storey RF
Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
[TBL] [Abstract][Full Text] [Related]
20. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
